Cargando…
Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade(®)
Biologics are produced from living organisms in complex, multi-stage manufacturing processes and contain inherent variability, which must be understood and controlled during manufacturing to avoid unexpected changes in key quality attributes that may contribute to clinically meaningful differences....
Autores principales: | Melsheimer, Richard, Calmann, Melissa, DeRitis, Albert, Philip, Vinod, Van Gog, Frank, Doolittle, Lawrence, Goyal, Kavitha, Neblock, Donald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182491/ https://www.ncbi.nlm.nih.gov/pubmed/30143982 http://dx.doi.org/10.1007/s40259-018-0300-7 |
Ejemplares similares
-
Remicade(®) (infliximab): 20 years of contributions to science and medicine
por: Melsheimer, Richard, et al.
Publicado: (2019) -
Ensuring excellence in patient care, research, and education: thoughts on leadership and teamwork
por: Spain, David A
Publicado: (2023) -
Comparability of Biologics: Global Principles, Evidentiary Consistency and Unrealized Reliance
por: Webster, Christopher J., et al.
Publicado: (2021) -
Infliximab (Remicade) in the treatment of psoriatic arthritis
por: Mease, Philip
Publicado: (2006) -
Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges
por: Sagili Anthony, Deva Priya, et al.
Publicado: (2021)